Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 48.45
-1.85 (-3.68%)
At close: Mar 2, 2026
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 677.61 million as of March 2, 2026. Its market cap has increased by 17.80% in one year.
Market Cap
677.61M
Enterprise Value
533.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48.45
Market Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 677.61M, an increase of 261.41%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 677.61M | -0.40% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 1.19B |
| Genovis AB (publ.) | 1.14B |
| Xspray Pharma AB | 1.13B |
| SynAct Pharma AB | 1.05B |
| Medivir AB | 921.13M |
| FluoGuide | 585.31M |
| Oncopeptides AB | 463.60M |
| Ascelia Pharma AB | 397.73M |